Expansion of the efficacy trial of Tele-Harm Reduction into a federally qualified health center operated syringe services program.

项目摘要 本申请是根据PA-20-272提交的，作为DP 2DA 053720的行政补充- 01（PI：Tookes）. T-SHARP（艾滋病毒和成瘾相关问题的远程医疗解决方案）试验将研究 在以下范围内运行的2个注射器服务项目（SSP）中的远程伤害减少干预的有效性 学术医疗中心，迈阿密大学/杰克逊卫生系统和南佛罗里达大学/坦帕 综合医院这一行政补充的目的是：1）扩大T-SHARP的远程试验， 对佛罗里达第三个艾滋病毒感染者PWID高患病率地点进行减少伤害干预，2）检查 执行障碍和促进者，以确定适当的执行战略， 在新的背景环境中实施远程伤害减少干预措施（联邦政府 合格的健康中心SSP）。第三个研究中心将把现有的试验扩大到七个中的三个。 佛罗里达（迈阿密-戴德县、希尔斯伯勒县和布劳沃德县）的艾滋病毒流行管辖区。这种扩大审判 研究中心和在新环境下实施干预措施的研究将确保研究符合入组目标 并且干预在不同SSP环境中是可行的。

PROJECT ABSTRACT This application is being submitted in response to PA-20-272 as an administrative supplement to DP2DA053720- 01 (PI: Tookes). The T-SHARP (Telehealth Solution to HIV and Addiction-Related Problems) trial will study the efficacy of the Tele-Harm Reduction intervention in 2 syringe services programs (SSPs) operated within academic medical centers, University of Miami/Jackson Health System and University of South Florida/Tampa General Hospital. The aims of this administrative supplement are 1) to expand the T-SHARP trial of the Tele- Harm Reduction intervention to a third site in Florida with a high prevalence of PWID with HIV and 2) to examine implementation barriers and facilitators to identify appropriate implementation strategies to facilitate implementation of the Tele-Harm Reduction intervention within a new contextual environment (a Federally Qualified Health Center based SSP). The third site will expand the existing trial to three of the seven Ending the HIV Epidemic jurisdictions in Florida (Miami-Dade, Hillsborough, and Broward Counties). This expansion of trial sites and study of the intervention implementation in a new context will ensure the study meets enrollment targets and that the intervention is feasible in varying SSP environments.